Ramberg H, Zucknick M, Barletta F, Davik P, Nybøen Å, Eri LM, Sivanesan S, Hole KH, Hompland T, Prestbakk SO, Gandaglia G, Bathen TF, Briganti A, Berge V, Austild Tasken K (2025)
Development and evaluation of a lymph node invasion risk prediction model in intermediate- and high-risk prostate cancer patients
Acta Oncol, 64, 1446-1454
DOI 10.2340/1651-226X.2025.43970, PubMed 41123130

Kalamara A, Stamatelatos IE, Stefanopoulos KL, Kalef-Ezra JA, Georgakilas AG, Stewart RD, Rangos V, Knudsen KD, Helgesen G, Trtik P, Mannes D, Hovind J, Kaestner A, Strobl M, Vinš M, Klupák V, Rabochová M, Šoltés J, Milčák J, Grigalavicius M, Theodossiou TA (2025)
A dosimetric and biological model for neutron capture therapy (NCT) experiments
Appl Radiat Isot, 226, 112233
DOI 10.1016/j.apradiso.2025.112233, PubMed 41086490

Høyvik AJK, Stenberg VY, Liukaityte R, Repetto-Llamazares A, Peng Q, Wangen-Riise R, Wiig E, Ma LW, Revheim ME, Juzeniene A (2025)
Optimizing [²¹²Pb]Pb-AB001 Radiopharmaceutical Therapy Schedules in PSMA-Positive Subcutaneous Prostate Cancer Xenografts
J Nucl Med (in press)
DOI 10.2967/jnumed.125.270444, PubMed 41043994